|
1
|
Shen WT, Grogan R, Vriens M, Clark OH and
Duh QY: One hundred two patients with pheochromocytoma treated at a
single institution since the introduction of laparoscopic
adrenalectomy. Arch Surg. 145:893–897. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Domi R and Laho H: Management of
pheochromocytoma: Old ideas and new drugs. Niger J Clin Pract.
15:253–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thouennon E, Pierre A, Yon L and Anouar Y:
Expression of trophic peptides and their receptors in chromaffin
cells and pheochromocytoma. Cell Mol Neurobiol. 30:1383–1389. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kitamura K, Kangawa K, Kawamoto M, Ichiki
Y, Nakamura S, Matsuo H and Eto T: Adrenomedullin: A novel
hypotensive peptide isolated from human pheochromocytoma. 1993.
Biochem Biophys Res Commun. 425:548–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong HK, Cheung TT and Cheung BM:
Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc Dis.
1:ii2012.
|
|
6
|
Cheung BM and Tang F: Adrenomedullin:
Exciting new horizons. Recent Pat Endocr Metab Immune Drug Discov.
6:4–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shimosawa T and Fujita T: Adrenomedullin
and its related peptide. Endocr J. 52:1–10. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nishikimi T, Kuwahara K, Nakagawa Y,
Kangawa K and Nakao K: Adrenomedullin in cardiovascular disease: A
useful biomarker, its pathological roles and therapeutic
application. Curr Protein Pept Sci. 14:256–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arjamaa O and Nikinmaa M: Natriuretic
peptides in hormonal regulation of hypoxia responses. Am J Physiol
Regul Integr Comp Physiol. 296:R257–R264. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arjamaa O and Nikinmaa M: Hypoxia
regulates the natriuretic peptide system. Int J Physiol Pharmacol.
3:191–201. 2011.
|
|
11
|
Arjamaa O and Nikinmaa M: Oxygen and
natriuretic peptide secretion from the heart. Int J Cardiol.
167:1089–1090. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arjamaa O: Physiology of natriuretic
peptides: The volume overload hypothesis revisited. World J
Cardiol. 6:4–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clerico A, Giannoni A, Vittorini S and
Passino C: Thirty years of the heart as an endocrine organ:
Physiological role and clinical utility of cardiac natriuretic
hormones. Am J Physiol Heart Circ Physiol. 301:H12–H20. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Federico C: Natriuretic Peptide system and
cardiovascular disease. Heart views. 11:10–15. 2010.PubMed/NCBI
|
|
15
|
Kuhn M: Endothelial actions of atrial and
B-type natriuretic peptides. Br J Pharmacol. 166:522–531. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu WW and Qi YF: Cardiovascular effects
and pathophysiological significance of adrenomedullin family
peptides. Sheng Li Ke Xue Jin Zhan. 44:177–182. 2013.(In Chinese).
PubMed/NCBI
|
|
17
|
Chollet-Dallon E, Stoermann-Chopard C and
Martin PY: Could cystatine C replace creatinine as a market of
glomerular filtration rate? Revue medicale suisse. 2:582–585.
2006.PubMed/NCBI
|
|
18
|
Mancia G, De Backer G, Dominiczak A,
Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE,
Laurent S, et al: 2007 Guidelines for the management of arterial
Hypertension: The task force for the management of arterial
hypertension of the european society of hypertension (ESH) and of
the European Society of Cardiology (ESC). J Hypertens.
25:1105–1187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohta H, Tsuji T, Asai S, Tanizaki S,
Sasakura K, Teraoka H, Kitamura K and Kangawa K: A simple
immunoradiometric assay for measuring the entire molecules of
adrenomedullin in human plasma. Clin Chim Acta. 287:131–143. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grzywa-Celińska A, Celiński R, Kwaśniewska
K, Dyczko M, Prystupa A and Mosiewicz J: The usefulness of
natriuretic peptides measurements in the diagnostics of chosen
cardiovascular diseases. Pol Merkur Lekarski. 34:232–234. 2013.(In
Polish). PubMed/NCBI
|
|
21
|
Lenders JW, Eisenhofer G, Mannelli M and
Pacak K: Phaeochromocytoma. Lancet. 366:665–675. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miller RA and Ohrt DW: Pheochromocytoma -
review and biochemical workup. S D Med. 66:267 269–270. 2013.
|
|
23
|
Marín MR, Arenas MF, Valverde FM, Garaulet
ET, Maderuelo MM, Avilés AM, Quirante FP and Blázquez AA:
Laparoscopic adrenalectomy for nonfamilial adrenal medullary
hyperplasia. JSLS. 17:433–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mannelli M, Lenders JW, Pacak K, Parenti G
and Eisenhofer G: Subclinical phaeochromocytoma. Best practice
& research. Best Pract Res Clin Endocrinol Metab. 26:507–515.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bovio S, Cataldi A, Reimondo G, Sperone P,
Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti
GV, et al: Prevalence of adrenal incidentaloma in a contemporary
computerized tomography series. J Endocrinol Invest. 29:298–302.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bełtowski J and Jamroz A:
Adrenomedullin-what do we know 10 years since its discovery? Pol J
Pharmacol. 56:5–27. 2004.PubMed/NCBI
|
|
27
|
Kato J, Kitamura K and Eto T: Plasma
adrenomedullin level and development of hypertension. J Hum
Hypertens. 20:566–570. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Al-Omari MA, Khaleghi M, Mosley TH Jr,
Turner ST, Morgenthaler NG, Struck J, Bergmann A and Kullo IJ:
Mid-regional pro-adrenomedullin is associated with pulse pressure,
left ventricular mass and albuminuria in African Americans with
hypertension. Am J Hypertens. 22:860–866. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhandari SS, Davies JE, Struck J and Ng
LL: The midregional portion of proadrenomedullin is an independent
predictor of left ventricular mass index in hypertension.
Metabolism. 59:7–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Coutinho T, Al-Omari M, Mosley TH Jr and
Kullo IJ: Biomarkers of left ventricular hypertrophy and remodeling
in blacks. Hypertension. 58:920–925. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishida H, Horio T, Suzuki Y, Iwashima Y,
Kamide K, Kangawa K and Kawano Y: Plasma adrenomedullin as an
independent predictor of future cardiovascular events in high-risk
patients: Comparison with C-reactive protein and adiponectin.
Peptides. 29:599–605. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sergeeva IA and Christoffels VM:
Regulation of expression of atrial and brain natriuretic peptide,
biomarkers for heart development and disease. Biochim Biophys Acta.
1832:2403–2413. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saito Y: Roles of atrial natriuretic
peptide and its therapeutic use. J Cardiol. 56:262–270. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Soualmia H, Ayadi I, Omar S, Feki M,
Drissa H, Mebazaa A and Kaabachi N: Atrial natriuretic peptide and
brain natriuretic peptide release in human essential hypertension.
Clin Lab. 55:120–127. 2009.PubMed/NCBI
|
|
35
|
Letizia C, De Toma G, Caliumi C, Cerci S,
Massa R, Loria RD, Alo P, Marinoni EM, Diacinti D and D'Erasmo E:
Plasma adrenomedullin concentrations in patients with adrenal
pheochromocytoma. Horm Metab Res. 33:290–294. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cotesta D, Caliumi C, Alò P, Petramala L,
Reale MG, Masciangelo R, Signore A, Cianci R, D'Erasmo E and
Letizia C: High plasma levels of human chromogranin A and
adrenomedullin in patients with pheochromocytoma. Tumori. 91:53–58.
2005.PubMed/NCBI
|
|
37
|
Vindenes T, Crump N, Casenas R and Wood K:
Pheochromocytoma causing cardiomyopathy, ischemic stroke and acute
arterial thrombosis: A case report and review of the literature.
Conn Med. 77:95–98. 2013.PubMed/NCBI
|
